期刊文献+

寻常型进展期白癜风患者外周血T淋巴细胞Fas和FasL的表达 被引量:3

The Fas and FasL expression of peripheral blood T lymphocytes in the patients with active vitiligo vulgaris
下载PDF
导出
摘要 目的:检测寻常型进展期白癜风患者外周血T淋巴细胞Fas和FasL的表达。方法:随机采集30例寻常型进展期白癜风患者(实验组)外周血3mL,分离T淋巴细胞后进行细胞涂片,使用免疫组化和原位杂交方法检测Fas和FasL蛋白和FasLmRNA水平的表达。并以30例静止期患者(对照组A)和20例健康志愿者(对照组B)作对照。结果:3组间Fas的表达差异无统计学意义(P>0.05)。与两组对照组相比,实验组FasL的表达明显增加(P<0.001)。与对照组B相比,对照组AFasL的表达显著增加(P<0.001)。结论:寻常型进展期白癜风患者外周血T淋巴细胞FasL的表达显著增加。 Objective: To detect the Fas and FasL expression in peripheral blood T lymphocytes in the patients with active vitiligo vulgaris. Methods: The peripheral blood was collected in 60 patients with vitiligo vulgaris (30 active; 30 static) and 20 health controls. Then T lymphocytes were isolated and were smeared to a slide. The immunohistochemistry and in site hybridization were employed to detect the expression of Fas and FasL, respectively. Results: There was no significant difference in the levels of Fas expression between each two of the three groups (P 〉 0.05). Comparing to static vitiligo group and health control, the FasL expressions were significantly higher in the active vitiligo group (P〈 0.01). Meanwhile, compared with health controls, the expression of FasL were higher in the static vitiligo group (P 〈 0.001). Conclusion: The FasL expressions in the peripheral blood lymphocytes of patients with active vitiligo vulgaris are significantly increased.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2006年第3期147-148,共2页 Journal of Clinical Dermatology
关键词 白癜风 进展期 寻常型 Fas(APO-1/CD95) FASL T淋巴细胞 vitiligo, active, vulgaris Fas (APO-1/CD95) FasL T lymphocyte
  • 相关文献

参考文献7

  • 1Le Poole IC,van den Wijngaard RM,Westerhof W,et al.Presence or absence of melanocytes in vitiligo lesions:an immunohistochemical investigation[J].J Invest Dermatol,1993,100(6):816-822.
  • 2Le Poole IC,van den Wijngaard RM,Westerhof W,et al.Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance[J].Am J Pathol,1996,148(4):1219-1228.
  • 3Cohen JJ.Apoptosis[J].Immunol Today,1993,14(3):126-130.
  • 4白癜风临床分型及疗效标准(2003年修订稿)[J].中华皮肤科杂志,2004,37(7):440-440. 被引量:801
  • 5Huang CL,Nordlund JJ,Boissy R.Vitiligo:a manifestation of apoptosis?[J].Am J Clin Dermatol,2002,3(5):301-308.
  • 6Das PK,van den Wijngaard RM,Wankowicz-Kalinska A,et al.A symbiotic concept of autoimmunity and tumour immunity:lessons from vitiligo[J].Trends Immunol,2001,22(3):130-136.
  • 7卢红阳,许冰,蔡卫民,吴蓓玲,阮黎明,李敏伟,范维薇,蒋颜,沈斌,宋晓静.白癜风患者外周血淋巴细胞Fas及Fas配体和可溶性Fas的研究[J].中华皮肤科杂志,2003,36(11):640-642. 被引量:5

二级参考文献10

  • 1Nozawa K;Kayagaki N;Tokano Y.Soluble Fas (Apo-1,CD95) and soluble Fas ligand in rheumatic diseases,1997.
  • 2全国中西医结合皮肤性病学会色素病学组.白癜风临床分型及疗效标准(草案),1995.
  • 3Nihei Y;Nishibu A;Kaneko F.Suplatast tosilate (IPD), a new immunoregulator, is effective in vitiligo treatment,1998(25).
  • 4Hamzaoui K;Hamzaoui A;Zakraoui L.Levels of soluble Fas/APO-1 in patients with Behcet′s disease[J],1998.
  • 5Nose M;Ito MR;no M.Vascular lesions in mice with a deficit in Fas-mediated apoptosis and their transfer[J],1996.
  • 6Wang J;Koizuni T;Watanabe T.Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice[J],1996.
  • 7Gonzalez-Cuadrado S;Lopez-Armada M J;Gomez-Guerrero C.Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells[J],1996.
  • 8Yu HS;Chang KL;Yu CL.Alterations in IL-6,IL-8,GMCSF,TNF-alpha,and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo[J],1997.
  • 9Cheng J;Zhou T;Liu C.Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule[J],1994.
  • 10耿松梅,谭升顺,刘恩让,彭振辉.Fas、FasL表达在银屑病发病机理中的作用[J].中华皮肤科杂志,1999,32(2):89-91. 被引量:5

共引文献803

同被引文献43

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部